Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro (0.3% Ciprofloxacin Otic Foam) Compared to Twice-Daily Dosing of Ciloxan (0.3% Ciprofloxacin Otic Solution) in Patients With Acute External Otitis.

Trial Profile

Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro (0.3% Ciprofloxacin Otic Foam) Compared to Twice-Daily Dosing of Ciloxan (0.3% Ciprofloxacin Otic Solution) in Patients With Acute External Otitis.

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Mar 2011

At a glance

  • Drugs Ciprofloxacin (Primary) ; Ciprofloxacin
  • Indications Bacterial infections; Otitis externa
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Mar 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
    • 14 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top